This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Arcutis Biotherapeutics, Inc., a for-profit manufacturer. The contract has a ceiling value of $7,000,000.00 and a period of performance that expires on January 14, 2028. The contract is for the delivery of "DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS" under the FSS contract number 65 I B. The scope of the contract includes the...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Ars Pharmaceutical Operations, Inc. The $1,025,000.00 contract is for the delivery of drugs, pharmaceuticals, and hematology-related products under FSS Schedule 65 I B. The contract has a period of performance from September 15, 2024 to March 14, 2025 and was set up as a multiple award vehicle with no set-asides. As an FSS contract, the awarded prime contractor...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Metacel Pharmaceuticals LLC, a for-profit organization. The contract is for the delivery of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B of the Federal Supply Schedule. The contract has a ceiling value of $25,000.00 and a period of performance from August 4, 2024, to January 31, 2025. This is an interim agreement with no...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Ars Pharmaceuticals Operations, Inc. The contract has a period of performance from March 15, 2025 to March 14, 2030 and a ceiling value of $225,000.00. The contract is for the delivery of Drugs, Pharmaceuticals, & Hematology Related Products under Federal Supply Schedule 65 IB. No specific task orders or price lists were provided, but the contract aims to...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government, to Biofrontera Inc., a for-profit organization. The contract has a ceiling value of $225,000.00 and a period of performance from June 15, 2024, to June 15, 2029. The contract is for the delivery of Drugs, Pharmaceuticals, & Hematology Related Products (FSC 65 I B) to the VISN 12 agency. While no set-asides were used, the contract was...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to ITF Therapeutics LLC, a foreign-owned, self-certified small disadvantaged business. The contract is for INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, with a ceiling value of $25,000.00 and a period of performance through May 14, 2025. As a Federal Supply Schedule contract, this is a multiple award vehicle...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Currax Pharmaceuticals LLC. The contract is for the delivery of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B of the Federal Supply Schedule program. The contract has a ceiling value of $25,000.00 and a period of performance through November 30, 2024. As a Federal Supply Schedule contract, this is a multiple award vehicle that...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs. The contract, valued at a ceiling of $300,000.00, was awarded to Yaral Pharma Inc., a for-profit manufacturer, for a period of performance ending on April 30, 2028. The contract falls under Schedule 65 I B, "DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS", and is intended to provide the agency...
This is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Bioxcel Therapeutics, Inc. The contract has a ceiling value of $25,000.00 and a period of performance through February 14, 2023. The contract is for an "Interim Agreement under FSS Schedule 65 I B Drugs, Pharmaceuticals, & Hematology Related Products." This indicates the contract provides for the delivery of pharmaceutical and related...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian U.S. federal agency, to Spectrum Pharmaceuticals, Inc., a for-profit manufacturer. The contract, with a ceiling value of $25,000.00, is for the delivery of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B of the Federal Supply Schedule. The contract period of performance extends from the award date of December 16, 2022 to the ultimate completion...